echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hesco cyclophenol injections are approved for listing by the NMPA

    Hesco cyclophenol injections are approved for listing by the NMPA

    • Last Update: 2020-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: MED2.0 China Drug Review Database Cyclophenol is GABAA-subjected atrial asticity sedative.
    only two of the five previously approved new narcotic drugs were Class 1 new drugs (Hengrui announced on January 3, 2020 that toluazoleon for injection toluene was approved for listing).
    approved this time, making it the third new Class 1 drug to go on sale this year.
    In China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal nervous system drug market, sales of narcotic drugs have exceeded 16 billion yuan, the growth rate in 2018-2019 remained above 10%, the first half of 2020 affected by the epidemic patients reduced the frequency of surgery, the growth rate fell by 15%.
    source: NMPA official website, MiNet database
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.